Burkitt's Lymphoma-Leukemia in Patients Treated for Hodgkin's Disease
作者:
SalloumEmile,
TalliniGiovanni,
LevyArthur,
CooperDennis L,
期刊:
Cancer Investigation
(Taylor Available online 1996)
卷期:
Volume 14,
issue 6
页码: 527-533
ISSN:0735-7907
年代: 1996
DOI:10.3109/07357909609076898
出版商: Taylor&Francis
数据来源: Taylor
摘要:
We reviewed all reported cases of Burkitt's lymphoma and/or Burkitt's leukemia (BLL) occurring following therapy for Hodgkin's disease. In addition to the case described in this report, a total of 19 patients have been previously reported. The male/female ratio was 3.75. Treatment for Hodgkin's disease included chemotherapy combined with radiation therapy in 15 patients, chemotherapy in 3 patients, and radiation therapy alone in 1 patient. Median interval between Hodgkin's disease and the diagnosis of BLL was 97 months. Patient characteristics are similar to those with de novo BLL. Bone marrow, abdomen, central nervous system, as well as extranodal organs were commonly involved. Typical cytogenetic translocations seen in patients with primary BLL were found in 6 patients, but 5 of these patients had additional cytogenetic abnormalities. Only 2 patients achieved complete remission after chemotherapy. The mechanism for the development of BLL after treatment for Hodgkin's disease is unknown. Although the majority of cases have been seen in patients treated with combined-modality therapy, the role of previous therapy in causing this complication cannot be assessed in this study.
点击下载:
PDF (1306KB)
返 回